SLC7A11 and hepatocellular carcinoma: Yes1‐associated transcriptional regulator (YAP1) and WW domain‐containing transcription regulator 1 (WWTR1, also called TAZ), well‐characterised transcriptional effectors of Hippo signalling, have also been implicated as key factors in Sorafenib resistance in hepatocellular carcinoma by increasing SLC7A11 expression.53